This is the authors' abstract. We don't add key points for this paper.
Localized Cutaneous Leishmaniasis (LCL) is a chronic disease characterized by ulcerated skin lesion(s) and uncontrolled inflammation. The mechanisms underlying its pathogenesis are not completely understood and little is known about posttranscriptional regulation during LCL. MicroRNAs (miRNAs) are non-coding small RNAs that regulates gene expression, which can be implicated in the pathogenesis of LCL. Then, we investigated the involvement of miRNAs and their targets genes in human LCL using publicly available transcriptome data sets, followed by ex vivo validation. Initial analysis highlighted that miRNAs expression is altered during LCL, clustering patients separately from controls. Joint analysis identified 8 high confidence miRNAs altered (-1.5≤fold change≥1.5; p<0.05) between cutaneous ulcers and uninfected skin. We found that the expression of miR-193b and miR-671 are greatly associated with their target genes, CD40 and TNFR, indicating an important role of these miRNAs in the expression of genes related to the inflammatory response observed in LCL. Besides, network analysis revealed that, miR-193b, miR-671 and TREM1 correlate only in patients that shows faster wound healing (up to 59 days) than in patients with longer time of cure (more than 60 days). Given that these miRNAs are associated with the control of inflammation and time of healing, our findings reveal that they might influence the pathogenesis and prognosis of LCL.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nunes et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: